Serotonin

Serotonin
Abbreviation	5-HT
Molecular formula	C₁₀H₁₂N₂O
Type	Monoamine neurotransmitter/hormone
Administration	N/A, doesn't cross blood-brain barrier; precursors like tryptophan/5-HTP used instead
Bioavailability	N/A
Synonyms	5-hydroxytryptamine
Source	Gut enterochromaffin cells (~90%), platelets, brainstem raphe nuclei
Ray's verdict	Generally hurts In the bioenergetic frame, excess serotonin is a stress and inflammation signal, not "happiness chemistry"

Serotonin is a monoamine made from the amino acid tryptophan. Gut cells make most of the body's store. Platelets carry it in blood. The brain makes a smaller share for local use.

Drug marketing sold high serotonin as the chemistry of happiness. In the bioenergetic frame, excess serotonin is a stress and inflammation signal. It constricts vessels, impairs energy production, and helps lock in learned helplessness.

In learned helplessness, the level of serotonin is high, and an excess of serotonin helps to create the state of learned helplessness.

— Ray Peat

History

Etymology

The name combines Latin serum with "tonic," describing the substance's vasotonic effect: a factor found in blood serum that constricts blood vessels.

Maurice Rapport, Arda Green, and Irvine Page isolated and named serotonin in 1948, identifying it as the vasoconstrictor factor in clotted blood; it was later found to also act as a neurotransmitter in the brain and gut.

Serotonin was isolated and named in 1948 by Maurice Rapport, Arda Green, and Irvine Page, who found it in blood serum and identified it as the substance responsible for constricting blood vessels ("tonic" effect on vascular tone). Its name combines "sero-" (serum) and "tonin" (from that vessel-tightening, tonic action). It was independently isolated from intestinal tissue around the same period under the name "enteramine," before the two were shown to be the same molecule.

Structure/Chemical properties

Serotonin (5-hydroxytryptamine, C₁₀H₁₂N₂O) is an indoleamine, built by adding a hydroxyl group to the amino acid tryptophan (via tryptophan hydroxylase) and then removing a carboxyl group (via aromatic amino acid decarboxylase). It does not cross the blood-brain barrier itself, so brain serotonin is synthesized locally from tryptophan that does cross, and is chemically and functionally separate from the much larger gut/platelet pool.

Function/Mechanism of Action

Estrogen activates the pathway that turns tryptophan into serotonin. Progesterone does the opposite. High estrogen and low progesterone raise serotonin tone as one system, not as two unrelated lab values.

Human genetics ties gut-derived serotonin directly to bone mass. People with a gain-of-function mutation in the Wnt-pathway co-receptor LRP5 have unusually high bone density along with a thickened jaw and palate, and their circulating serotonin runs low; people with loss-of-function LRP5 mutations develop osteoporosis and have elevated serotonin instead. LRP5 acts, in part, by suppressing Tph1, the rate-limiting enzyme for serotonin synthesis in gut enterochromaffin cells of the duodenum; the serotonin that escapes this brake acts on osteoblasts through the Htr1b receptor to inhibit their proliferation, so more gut serotonin means less new bone.

Gut endotoxin and inflammation free platelet serotonin and amplify systemic effects. Hyperventilation raises serotonin and histamine as CO2 falls. A high-tryptophan muscle-meat pattern without gelatin or other glycine-rich protein feeds the same pool. See Estrogen, Endotoxin, CO2, Gelatin.

Airborne ion charge also shifts brain serotonin. In mice held under controlled pollutant-free conditions, small negative air ions lowered brain serotonin within 12 hours of exposure, while positive ions raised it; the same polarity split showed up in blood serotonin measurements. Natural settings with high negative-ion density, such as waterfalls and open water, are one proposed route by which time outdoors could lower serotonin tone independent of light or exercise. A controlled trial in 32 patients with chronic depression tested this directly: an hour of daily home exposure to high-density negative air ions produced a 51.1% improvement on the SIGH-SAD depression scale and a 50% remission rate over 5 weeks, matching bright light therapy (53.7% improvement, 50% remission) and far outperforming a low-density placebo ion generator (17.0% improvement, 0% remission).

Depressed patients show evidence of disrupted blood-brain barrier integrity, including altered cerebrospinal-fluid/blood ratios of various molecules, and greater blood-brain barrier leakage in bipolar patients tracks with more severe depression. Serotonin acting on the 5-HT4 receptor on brain microvascular endothelial cells increases blood-brain barrier permeability by downregulating the tight-junction protein occludin, one candidate mechanism for how elevated serotonin could open the barrier in depression.

Hibernation, darkness, and schizophrenia

Serotonin release drives the hibernation reaction: as an animal approaches hibernation and produces less CO2, the resulting serotonin release slows respiration, lowers temperature, suppresses appetite, and produces torpor. Peat called serotonin "the torpor-hibernation chemical" and noted that it "powerfully interferes with learning." He proposed that nocturnal sleep's special function is minimizing the stress of darkness itself.

I suspect that nocturnal sleep has the special function of minimizing the stress of darkness itself, and that it has subsidiary functions, including its now well confirmed role in the consolidation and organization of memory.

— Ray Peat

Peat tied the same serotonin/stress axis to schizophrenia: "Schizophrenia is one outcome of stress, both cumulative and acute," and noted that prenatal stress commonly predisposes a person to develop schizophrenia at a later age. See Schizophrenia for the fuller serotonin-versus-dopamine treatment picture, including why drugs that block serotonin (with or without also raising dopamine tone) relieve symptoms.

Clinical significance

Vessels tighten. Oxidative metabolism falls. Mood can look like helpless depression rather than simple "low serotonin sadness." Gut motility swings. Fibrosis and inflammatory shock lines appear when serotonin stays high. Antiserotonin drugs show up in fibrosis and leak-related research for that reason.

This is not advice to stop psychiatric serotonin drugs from a wiki page. Those drugs change receptor systems over time. Stopping them without medical care is dangerous. The page describes a metabolic reading of serotonin tone, not a deprescribing protocol. See Harm reduction, Serotonin syndrome.

Animal evidence: brain ATP collapse and anaerobic glycolysis

Injecting rats with serotonin drops brain ATP and raises inorganic phosphate, while cytosolic phosphofructokinase (the rate-limiting glycolytic enzyme) becomes more active; lactate climbs at the same time, the same energetic signature seen in cerebral ischemia. Plasma hemoglobin also rose, reflecting red-cell lysis. The calmodulin antagonists trifluoperazine and thioridazine blocked all of these changes, pointing to a calmodulin-dependent step behind serotonin's acute hit to brain energy production.

SSRI developmental neurotoxicity

In a human iPSC-derived 3D brain organoid model, the SSRI paroxetine at therapeutic blood concentrations caused an 80% decrease in synaptic markers, a 60% decrease in neurite outgrowth, and a 40-75% decrease in oligodendrocyte populations -- an in-vitro developmental-neurotoxicity finding, not a direct human pregnancy outcome study, though the authors note it as consistent with prior epidemiological links between prenatal SSRI exposure and autism risk.

Acetylcholine drives striatal serotonin release in OCD models

Cholinergic interneurons in the dorsal striatum directly trigger local serotonin release via nicotinic acetylcholine receptors on serotonergic axons, a coupling absent in the ventral striatum despite its denser serotonergic innervation. In Sapap3-knockout mice, a model of obsessive-compulsive-like behavior, this cholinergic system runs in overdrive, selectively amplifying serotonin release -- consistent with excess acetylcholine, not a primary serotonin deficit, driving the compulsive phenotype.

Gut serotonin drives obesity via blocked thermogenesis

TPH1, the rate-limiting enzyme for peripheral serotonin synthesis in the gut, runs about 40% higher in obese humans, and obesity increases peripheral serotonin more broadly. In mice, genetically deleting Tph1, or chemically inhibiting it with a small molecule, protects against diet-induced obesity, insulin resistance, and fatty liver while increasing energy expenditure, an effect that requires UCP1-mediated brown-fat thermogenesis; serotonin directly blunts the induction of that thermogenic program in brown and beige fat cells.

Sensory gating

Serotonin dampens rather than sharpens sensory throughput at the circuit level in at least two systems. In the olfactory bulb, serotonergic fibers activate periglomerular interneurons that release GABA to suppress transmitter release from olfactory sensory neurons, gating down odor signal before it reaches higher processing. In the auditory cortex, "loudness dependence of auditory evoked potentials" (LDAEP) is used as an inverse marker of central serotonergic tone: rat electrophysiology combined with microdialysis found higher extracellular serotonin in primary auditory cortex tracked with a flatter, more dampened cortical response to increasing sound intensity, while a serotonin-lowering agent restored a steeper, more differentiated response curve. Both findings support serotonin as a general damping signal on sensory circuits rather than establishing a broad claim across every sense.

Blocking serotonin relieves opioid withdrawal

The broad-spectrum serotonin antagonist mirtazapine relieved the full spectrum of opioid-withdrawal symptoms, including nausea, diarrhea, anxiety, and jitteriness, consistent with the withdrawal syndrome being driven substantially by excess serotonin rather than by serotonin loss.

Public perception

Ray Peat pointed to encyclopedic sources, including Wikipedia's own serotonin article, as evidence of how thoroughly the "happiness hormone" framing has displaced the older, more accurate stress/inflammation-signal view in public understanding, comparing that framing's spread to the influence of corporate advertising and public relations on popular science writing.

Lowering the load as one set

The levers work together. Lower PUFA and endotoxin so the gut and liver are not constantly dumping inflammatory and serotonergic signals. Support thyroid and progesterone so estrogen-driven synthesis falls. Keep glucose and CO₂-retaining breathing so energy stays high enough to exit the helpless state. Use gelatin or other low-tryptophan protein to balance muscle meat. Coffee and aspirin appear in the same practical set as supports that reduce free serotonin impact and inflammatory tone.

Low appetite in hypothyroid or inflammatory states blocks repair; cyproheptadine and progestogenic contexts appear in clinical and community discussion for raising appetite by blunting serotonin tone. Forcing large meals when nauseated fails; liquid calories help instead.

No single pill replaces that set. Cyproheptadine and other antiserotonin tools are advanced topics with their own risks. See Cyproheptadine, Thyroid, Progesterone, Coffee.

Avoiding prolonged fasting and stressful exercise that increase free fatty acids, and combining sugars with proteins to keep free fatty acids low, and using aspirin, niacinamide, or cyproheptadine to reduce the formation of free fatty acids by unavoidable stress, avoiding an excess of phosphate relative to calcium in the diet, having milk and other anti-stress foods at bedtime or during the night, and being in a brightly lighted environment during the day, with regular sunlight exposure, can minimize the harmful effects of excessive serotonin and reduce the inflammation, fibrosis, and atrophy associated with it.

— Ray Peat

See also

• Tryptophan
• Learned helplessness
• Stress
• Estrogen
• Progesterone
• Endotoxin
• CO2
• Gelatin
• Cyproheptadine
• Bone
• Harm reduction